medigraphic.com
ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)

2013, Number 1

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2013; 29 (1)

Deficiency of proteins C and S: trombotic risk markers

Zamora-González Y, Agramonte-Llanes OM, Rodríguez-Pérez L

Language: Spanish
References: 37
Page: 40-47
PDF size: 88.65 Kb.


ABSTRACT

For several centuries it has been known that coagulation defects cause hemorrhagic disease, but the study of its counterpart, thrombotic diseases, has been developed in more depth just a few decades ago. These disorders of coagulation system are one of the most common causes of death in the world today, where about two million people die every year from thrombosis, either arterial or venous. They are also considered an important source of morbidity in people who suffer it and survive. Hypercoagulable state or thrombophilia are clinical conditions that affect a number of patients with abnormal tendency to thrombotic events. Deficiency of protein C (PC) and protein S (PS) are causes of congenital or acquired thrombophilias that predispose to thromboembolic disorders, recurrent pregnancy loss, recurrent venous thrombosis, among others. Its diagnosis is very important it provides tools for its prophylaxis in order to reduce the risk of recurrence and the possibility of identify a carrier state in any other family member.


REFERENCES

  1. Dahlbäck B. Blood coagulation. Lancet. 2000 May;355(9215):1627-32.

  2. Mann KG, Van't Veer C, Cawthern K, Butenas S. The role of the tissue factor pathway in initiation of coagulation. Blood Coagul Fibrinolysis. 1998 Mar;9(Suppl 1):S3-7.

  3. Broze GJ, Jr. Tissue factor pathway inhibitor. Thromb Haemost. 1995 Jul;74(1):90-3.

  4. Dahlbäck B. The protein C anticoagulant system: inherited defects as basis for venous thrombosis. Thromb Res.1995 Jan;77(1):1-43.

  5. Virchow R. Cellular pathology. As based upon physiological and pathological histology. Lecture XVI- Atheromatous affeccion of arteries. 1958. Nutr Rev. 1989 Jan;47(1):23-5.

  6. Tripodi A, Mannucci P. Laboratory investigation of thrombophilia. Clin Chem. 2001 Sep;47(9):1597-606.

  7. Barger AP, Hurley R. Evaluation of the hypercoagulable state: whom to screen, how to test and treat. Postgrad Med. 2000 Sep 15;108(4):59-66.

  8. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med. 2001 Apr;344(16):1222-31.

  9. Orúe MT. Trombofilia e ictus. ANALES Sis San Navarra. 2000;23(Supl 3):39-45.

  10. Meijers JC, Herwald H. Protein C Inhibitor. Semin Thromb Hemost. 2011 Jun;37(4):349-54.

  11. Horellou MH, Van Dreden P, Conanrd J, Samama M. Intéret du dosage de la proteine C dans les accidents thomboemboliques veineux. Feuil Biol. 1985;26:27-31.

  12. Esmon CT, Esmon NL. Protein C activation. Semin Thromb Hemost. 1984 Apr;10(2):122-30.

  13. Sampol J, Arnoux D, Boutiere B. Manuel d^hémostase. París: Editions Scientifiques Elservier; 1995. p. 259-76.

  14. Mateo J. Prevalencia de las alteraciones biológicas causantes de trombofilia en la población española. Tesis doctoral. Barcelona; 2001. Disponible en: http://www.tdx.cat/handle/10803/4398

  15. Torres R, Ballona R. Púrpura fulminante asociada a deficiencia de proteína C, proteína S y resistencia a proteína C activada. Folia Dermatol Perú. 2005;16(1):33-7.

  16. Torres W, Colina A. Trombofilias. En: Suardíaz JH, Cruz CL, Colina AJ. Laboratorio Clínico. La Habana: Editorial Ciencias Médicas; 2004. P. 35061.

  17. Pereira JG. Trombofilia y trombosis arterial. Rev Chil Cardiol 2007;26:97-103.

  18. Plutzky J, Hoskins JA, Long GL, Crabtree GR. Evolution and organization of the human protein C gene. Proc Natl Acad Sci USA. 1986 Feb;83(3):546-50.

  19. Miletich J, Sherman L, Broze G. Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med. 1987 Oct;317(16):991-4.

  20. Koster T, Rosendaal FR, Briet E, van der Meer JFM, Colly LP, Trienekens PH, et al. Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study). Blood. 1995 May;85(10):2756-61.

  21. Dreyfus M, Masterson M, David M, Rivard GE, Müller FM, Kreuz W, et al. Replacement therapy with monoclonal antibody purified protein C concentrate in newborns with severe congenital protein C deficiency. Semin Thromb Hemost. 1995;21(4):371-81.

  22. Esnaola-Rojas MM. Diagnóstico y tratamiento de las coagulopatías. Rev Neurol. 1999 Dec;29(12):1290-300.

  23. Di Scipio RG, Hermodson MA, Yates SG, Davie EW. A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S. Biochemistry. 1977 Feb;16(4):698-706.

  24. Walker FJ. Regulation of activated protein C by a new protein. A possible function for bovine protein. J Biol Chem. 1980 Jun;255(12):5521-4.

  25. Bertina RM. Hereditary protein S deficiency. Haemostasis. 1985;15(4):241- 6.

  26. Altman R. Trombosis. Fisiología. Mecanismos de enfermedad y tratamiento. Buenos Aires: Editorial Akadia; 2005. p. 40-1.

  27. Walker FJ. Protein S and the regulation of activated protein C. Semin Thromb Hemost. 1984 Apr;10(2):131-8.

  28. Griffin JH, Heem MJ, Schwarz HP. Plasma protein S deficiency and thromboembolic disease. Prog Hematol. 1987;15:39-49.

  29. Dahlback B. Protein S and C4b binding protein: components involved in the regulation of the protein C anticoagulant system. Thromb Haemost. 1991 Jul;66(1):49-61.

  30. Takahashi H, Tatewaki W, Wada K, Shibata A. Plasma protein S in disseminated intravascular coagulation, liver disease, collagen disease, diabetes mellitus, and under oral anticoagulant therapy. Clin Chem Acta. 1989 Jun;182(2):195-208.

  31. Lietz K, Kuchling SE, Parkhurst JB. Hemorrhagic stroke in a child whit protein S and factor VII deficiencies. Pediatr Neurol. 2005 Mar;32(3):208-10.

  32. Zöller B, García de Frutos P, Dahlbäck B. Evaluation of the relationship between protein S and C4b-binding protein isoforms in hereditary protein S deficiency demostrating type I and type III deficiencies to be phenotypic variants of the same genetic disease. Blood 1995 Jun;85(12):3524-31.

  33. Joshi A, Jaiswal JP. Deep vein thrombosis in protein S deficiency. J Nepal Med Assoc. 2010 Jan-Mar;49(177):56-8.

  34. Yalinkaya A, Erdemoglu M, Akdeniz N, Kale A, Kale E. The relation between thrombophilic mutations and preeclampsia. Ann Saudi Med. 2006 Mar-Apr;26(2):105-9.

  35. Hamilton K, Salman MS, Schwartz I, McCusker PJ, Wrogemann J, Rafay MF. Arterial ischemic stroke in an adolescent with presumed perinatal ischemic stroke. J Child Neurol. 2012 Jan;27(1):94-8.

  36. Muwakkit SA, Majdalani M, Hourani R, Mahfouz RA, Otrock ZK, Bilalian C, et al. Inherited thrombophilia in childhood arterial stroke: data from Lebanon. Pediatr Neurol. 2011 Sep;45(3):155-8.

  37. Beeck H, Hellstern P, Hubbuch A. Effects of sex and oral contraceptives on the reference ranges of protein C. Haemostasis. 2000;1:127.




2020     |     www.medigraphic.com